The Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases
Authors:
Open Access
- 23 October 2025
- journal article
- Published by Galenos Yayinevi in Inherited Metabolic Disorders and Nutrition
Abstract
The Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases - Inherited Metabolic Disorders and NutritionKeywords
This publication has 19 references indexed in Scilit:
- A multiomics approach reveals evidence for phenylbutyrate as a potential treatment for combined D,L-2- hydroxyglutaric aciduriaMolecular Genetics and Metabolism, 2024
- The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuriaJournal of Inherited Metabolic Disease, 2024
- An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolismMolecular Genetics and Metabolism, 2023
- An international classification of inherited metabolic disorders (ICIMD)Journal of Inherited Metabolic Disease, 2020
- Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of MetabolismThe Journal of Applied Laboratory Medicine, 2020
- Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profilingMolecular Genetics and Metabolism, 2018
- Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuriaMolecular Genetics and Metabolism, 2017
- Rare disease: a focus on metabolomicsExpert Opinion on Orphan Drugs, 2016
- Perturbations of tyrosine metabolism promote the indolepyruvate pathway via tryptophan in host and microbiomeMolecular Genetics and Metabolism, 2015
- Green systems biology — From single genomes, proteomes and metabolomes to ecosystems research and biotechnologyJournal of Proteomics, 2011